share_log

Pfizer | 3: Initial statement of beneficial ownership of securities-Officer Baum Andrew

Pfizer | 3: Initial statement of beneficial ownership of securities-Officer Baum Andrew

輝瑞 | 3:首次持股聲明-高管 Baum Andrew
美股sec公告 ·  08/02 09:54
Moomoo AI 已提取核心訊息
Pfizer Executive Vice President Andrew Baum filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated August 1, 2024, indicates that Baum does not beneficially own any Pfizer securities. The document, which is a standard disclosure for insiders of publicly traded companies, was signed by Baum's attorney, Susan E. Grant, on August 2, 2024. This filing is in compliance with Section 16(a) of the Securities Exchange Act of 1934 and is a routine procedure for executives and directors to report their stock holdings in the company.
Pfizer Executive Vice President Andrew Baum filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated August 1, 2024, indicates that Baum does not beneficially own any Pfizer securities. The document, which is a standard disclosure for insiders of publicly traded companies, was signed by Baum's attorney, Susan E. Grant, on August 2, 2024. This filing is in compliance with Section 16(a) of the Securities Exchange Act of 1934 and is a routine procedure for executives and directors to report their stock holdings in the company.
輝瑞公司執行副總裁安德魯·鮑姆根據Form 3要求向SEC提交了一份有關證券的初始受益所有權聲明。該於2024年8月1日提交的備案文件顯示鮑姆並沒有受益擁有任何輝瑞公司的證券。該文件是公開交易公司內部人士必須刊登的標準披露文件,由鮑姆的律師Susan E. Grant於2024年8月2日簽署。這個備案符合《1934年證券交易法》第16(a)條的規定,是管理執行人員和董事的股票持有報告的例行程序。
輝瑞公司執行副總裁安德魯·鮑姆根據Form 3要求向SEC提交了一份有關證券的初始受益所有權聲明。該於2024年8月1日提交的備案文件顯示鮑姆並沒有受益擁有任何輝瑞公司的證券。該文件是公開交易公司內部人士必須刊登的標準披露文件,由鮑姆的律師Susan E. Grant於2024年8月2日簽署。這個備案符合《1934年證券交易法》第16(a)條的規定,是管理執行人員和董事的股票持有報告的例行程序。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息